Finance

Lists
300519:SHE
Zhejiang Xinguang Pharmaceutical Co Ltd
14,61 CN¥
+1,53%
(+0,22) 1D
16-окт., 15:04:25 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300519...
Open
14,48 CN¥
High
15,25 CN¥
Low
14,43 CN¥
Mkt. cap
2,34 млд
Avg. vol.
3,06 млн
Volume
6,06 млн
Dividend
2,05%
Quarterly dividend
0,07 CN¥
Ex-dividend date
2026-ж., 29-май
P/E ratio
37,69
52-wk high
18,25 CN¥
52-wk low
11,53 CN¥
EPS
0,39 CN¥
Shares outstanding
160,00 млн
No. of employees
309
Open
14,48 CN¥
High
15,25 CN¥
Low
14,43 CN¥
Mkt. cap
2,34 млд
Avg. vol.
3,06 млн
Volume
6,06 млн
Dividend
2,05%
Quarterly dividend
0,07 CN¥
Ex-dividend date
2026-ж., 29-май
P/E ratio
37,69
52-wk high
18,25 CN¥
52-wk low
11,53 CN¥
EPS
0,39 CN¥
Shares outstanding
160,00 млн
No. of employees
309
News stories
From web sources and news partners
About Zhejiang Xinguang Pharmaceutical Co Ltd
CEO-
Employees309
Founded1998-ж., 18-ноя.
Headquarters-
SectorPharmaceutical industry
Websitexgpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
64,68 млн
59,74 млн
88,47 млн
54,12 млн
Cost of goods sold
35,60 млн
37,97 млн
48,33 млн
28,36 млн
Cost of revenue
35,60 млн
37,97 млн
48,33 млн
28,36 млн
Research and development expenses
3,06 млн
3,31 млн
2,83 млн
4,05 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,41 млн
10,76 млн
8,04 млн
8,61 млн
Operating expense
10,29 млн
16,44 млн
11,75 млн
14,24 млн
Total operating expenses
45,89 млн
54,41 млн
60,08 млн
42,60 млн
Operating income
18,79 млн
5,33 млн
28,39 млн
11,52 млн
Other non operating income
-2,36 миң
-2,56 миң
-3,00 миң
-3,63 миң
EBT including unusual items
17,29 млн
9,86 млн
30,47 млн
14,99 млн
EBT excluding unusual items
19,90 млн
8,11 млн
30,36 млн
14,33 млн
Income tax expense
3,86 млн
980,05 миң
4,10 млн
1,64 млн
Effective tax rate
22,32%
9,94%
13,46%
10,97%
Other operating expenses
-251,59 миң
2,61 млн
1,04 млн
1,38 млн
Net income
13,43 млн
8,88 млн
26,37 млн
13,34 млн
Net profit margin
20,76%
14,86%
29,80%
24,65%
Earnings per share
-
-
-
-
Interest and investment income
1,12 млн
2,79 млн
1,98 млн
2,81 млн
Interest expense
-
-
-
-
Net interest expenses
1,12 млн
2,79 млн
1,98 млн
2,81 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
22,52 млн
9,01 млн
32,07 млн
14,97 млн
Gain or loss from assets sale
-3,72 миң
3,72 миң
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору